Eleos Pharmaceuticals, Inc. — Form D
Eleos Pharmaceuticals, Inc. of WATKINSVILLE, GA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-01. The offering totals $2.0M, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-10-01
- Form: D
- Accession: 0001885028-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Minimum investment: $500K
- Investors: 1
- Date of first sale: 2021-08-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-415377
Issuer
- Name: Eleos Pharmaceuticals, Inc.
- CIK: 0001885028
- Entity type: Corporation
- Jurisdiction: GEORGIA
- Incorporated: 2017
- Address: 1357 OCONEE CONNECTOR, WATKINSVILLE, GA, 30677
- Phone: 704-619-1289
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| David J Sailors | Director | Watkinsville, GA |
| Jonathan J Woody | Director | Watkinsville, GA |
| Christopher J Elliott | Executive Officer | Watkinsville, GA |
More